Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lacosamide intermediate compound and preparation method and application thereof

A compound, a phthalimide-based technology, is applied to the intermediate compound of the drug lacosamide and its preparation field, which can solve the problems of high price, unfavorable industrial production, and high production cost, and achieve low production cost and easy Industrialized production, high yield effect

Active Publication Date: 2011-08-10
ZHEJIANG JIUZHOU PHARM CO LTD
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The above reaction process prepares lacosamide, it is necessary to use very expensive methyl iodide and silver oxide, which is not conducive to industrial production; and when de-Cbz protection, use Pd-c catalyst, the production cost is higher

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lacosamide intermediate compound and preparation method and application thereof
  • Lacosamide intermediate compound and preparation method and application thereof
  • Lacosamide intermediate compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] The preparation of embodiment 1 (R)-N-benzyl-2-(tert-butoxycarbonyl amino)-3-hydroxyl propionamide

[0050]

[0051] Dissolve 32.16g (0.30mol) of benzylamine in 150g of anhydrous ethyl acetate to prepare a solution for later use.

[0052] Add 51.5g (0.25mol) (R)-2-(tert-butoxyamino)-3-hydroxypropionic acid and 450g anhydrous ethyl acetate in sequence to a 1000ml four-neck round bottom flask, and start mechanical stirring. Cool down to -10°C. 27.83 g (0.275 mol) of N-methylmorpholine and 37.59 g (0.275 mol) of isobutyl chloroformate were added to the system. After the addition, add the above-prepared benzylamine-ethyl acetate solution (32.16 g of benzylamine dissolved in 150 g of anhydrous ethyl acetate) at -15 to -10°C. Subsequently, the temperature was raised to 10-15° C., and the reaction was carried out with heat preservation. After the reaction is complete, add 200 g of tap water and stir for several minutes. Stand to separate layers and take the organic phas...

Embodiment 2

[0053] The preparation of embodiment 2 (R)-2-amino-N-benzyl-3-hydroxyl propionamide

[0054]

[0055] Add 34.0g (R)-N-benzyl-2-(tert-butoxycarbonylamino)-3-hydroxypropionamide and 350ml dichloromethane into a 500ml four-neck flask, stir to dissolve. Add 40.0 g of concentrated hydrochloric acid (mass concentration: 36.0%) at 20-25°C. Continue to react when done. TLC tracking, until the conversion of raw materials is complete. After the reaction was completed, the temperature was lowered to 20°C. After suction filtration, white needle crystals were obtained. The resulting white crystalline solid was dissolved in 50 g of water. Add 30% sodium hydroxide solution at 20-25°C to adjust the pH of the system to 8-9. After the addition, the stirring was continued, and white flaky crystals were precipitated. After suction filtration, washing and drying, 16.5 g (0.085 mol) of the target product was obtained with a molar yield of 73.52%.

Embodiment 3

[0056] The preparation of embodiment 3 (R)-N-benzyl-2-(ethoxycarbonylamino)-3-hydroxyl propionamide

[0057]

[0058] Add 9.65g (0.0497mol) (R)-2-amino-N-benzyl-3-hydroxypropionamide, 120ml tetrahydrofuran and 7.58g (0.07455mol) triethylamine to a 250ml three-necked flask, and stir to dissolve. Add 6.01 g (0.0554 mol) ethyl chloroformate at room temperature. After the reaction was completed, the solvent was evaporated to dryness, 100ml of water was added to the residue, and the mixture was stirred evenly. Extract with 50ml×3 ethyl acetate, combine the organic phases, and dry over anhydrous sodium sulfate. The solvent was evaporated to dryness to obtain 9.67 g (0.0363 mol) of white solid with a molar yield of 73.04%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a new compound, which can be used for preparing lacosamide, and provides a new method for preparing the lacosamide. In the reaction process, precious methyl iodide and silver oxide are not used, a Pd-c catalyst is not used, the production cost is low, raw materials and auxiliary materials are cheap and readily available, the process is easy to operate, and the industrial production is easy to realize; and the yield is high and the economic benefit is high.

Description

technical field [0001] The present invention relates to the fields of organic chemistry and medicinal chemistry, in particular to an intermediate compound of drug lacosamide, a preparation method and application thereof. Background technique [0002] Lacosamide, English name: Lacosamide, chemical name: (R)-N-benzyl-2-acetamido-3-methoxypropionamide ((R)-N-benzyl-2-acetamido-3-methoxypropionamide ), the CAS number is: 175481-36-4, and the structural formula is as follows: [0003] [0004] It is a drug for the treatment of epilepsy and neuropathic pain developed by Germany's Schwarz Biotechnology Company, and is used to assist in the treatment of partial seizures in patients aged 16 and above with or without secondary grand mal seizures. Lacosamide, also known as lacosamide, has a different mode of action than all other currently marketed antiepileptic drugs: this product modulates sodium channel activity, while other commercially available antiepileptic drugs block sodiu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C271/22C07C269/06C07C231/12C07C269/04C07C237/06C07C231/14
CPCC07C271/22C07C237/06C07C231/14
Inventor 张现毅董少卿车大庆
Owner ZHEJIANG JIUZHOU PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com